China considers ways to speed up time to market for imported drugs

BEIJING (Reuters) – China is considering taking measures that will shorten the time to market for approved imported drugs in an effort to ease a shortage of such medicines, according to the China Food and Drug Administration (CFDA).

Filed under: Emerging Markets